{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:18:23Z","timestamp":1785403103761,"version":"3.56.0"},"reference-count":117,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan","award":["AP23490103"],"award-info":[{"award-number":["AP23490103"]}]},{"award":["AP23490103"],"award-info":[{"award-number":["AP23490103"]}],"id":[{"id":"https:\/\/ror.org\/05tyne317","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Diabetic retinopathy (DR) is the leading cause of vision loss in early adulthood, caused by disruption of the retinal microvasculature. In the early stages of DR, there is a loss of pericytes, the cells responsible for maintaining vascular stability. Pericytes are progenitor cells and possess stem cell properties such as the potential to differentiate into various cell types, surface markers similar to mesenchymal stem cells (MSCs), and the ability to modulate the immune response. Human adipose-derived MSCs, when cultured with certain growth factors, acquire a pericyte-like phenotype, which expands the potential for pericyte applications in therapy. Current treatments for DR include anti-vascular endothelial growth factor agents, corticosteroids, and laser photocoagulation. All of these treatments are symptomatic and have adverse effects. This review covers the prevalence of DR in Kazakhstan and worldwide, the pathogenesis of the disease at the molecular and clinical level, treatment methods and modern approaches based on stem cells and pericytes.<\/jats:p>","DOI":"10.3390\/ijms27146354","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:00:52Z","timestamp":1784278852000},"page":"6354","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic Retinopathy and Current Treatment Approaches: From Pathogenesis to Extracellular Vesicle-Based Therapies"],"prefix":"10.3390","volume":"27","author":[{"given":"Madina","family":"Sarsenova","sequence":"first","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symbat","family":"Alimbek","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meruyert","family":"Imanbekova","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7486-5267","authenticated-orcid":false,"given":"Miras","family":"Shakhatbayev","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidar","family":"Dairov","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan"},{"name":"Department of General Biology and Genomics, L.N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Baidarbekov","sequence":"additional","affiliation":[{"name":"National Scientific Center of Traumatology and Orthopedics Named After Academician N.D. Batpenov, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Kadralieva","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Non-Profit Joint-Stock Company Astana Medical University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Urazayeva","sequence":"additional","affiliation":[{"name":"Astromed Vision Restoration Center, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamrat","family":"Tlebergenov","sequence":"additional","affiliation":[{"name":"Astromed Vision Restoration Center, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-2510","authenticated-orcid":false,"given":"Assel","family":"Issabekova","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-5255","authenticated-orcid":false,"given":"Vyacheslav","family":"Ogay","sequence":"additional","affiliation":[{"name":"Stem Cell Laboratory, National Center for Biotechnology, Astana 010000, Kazakhstan"},{"name":"Department of General Biology and Genomics, L.N. Gumilyov Eurasian National University, Astana 010008, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.21037\/atm-20-6737","article-title":"Animal model of diabetic retinopathy","volume":"9","author":"Quiroz","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/dme.12089","article-title":"Diabetic retinopathy: Pathogenesis, clinical grading, management and future developments","volume":"30","author":"Heng","year":"2013","journal-title":"Diabet. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ayres-Sander, C.E., Lauridsen, H., Maier, C.L., Sava, P., Pober, J.S., and Gonzalez, A.L. (2013). Transendothelial Migration Enables Subsequent Transmigration of Neutrophils through Underlying Pericytes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060025"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","article-title":"A new blood\u2013brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes","volume":"54","author":"Nakagawa","year":"2009","journal-title":"Neurochem. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_7","first-page":"271","article-title":"Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells","volume":"54","author":"Ahmed","year":"2020","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12015-023-10636-9","article-title":"A Systematic Review of Stem Cell Differentiation into Keratinocytes for Regenerative Applications","volume":"20","author":"Hazrati","year":"2024","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Caporarella, N., D\u2019Angeli, F., and Cambria, M.T. (2019). Pericytes in microvessels: From \u201cmural\u201d function to brain and retina regeneration. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246351"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s00125-018-4713-0","article-title":"Human adipose tissue-derived stromal cells act as functional pericytes in mice and suppress high-glucose-induced proinflammatory activation of bovine retinal endothelial cells","volume":"61","author":"Hajmousa","year":"2018","journal-title":"Diabetologia"},{"key":"#cr-split#-ref_11.1","unstructured":"(2021). GBD 2019 Blindness and Vision Impairment Collaborators"},{"key":"#cr-split#-ref_11.2","doi-asserted-by":"crossref","unstructured":"Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob. Health, 9, e144-e160. Erratum in Lancet Glob. Health\u00a02021, 9, e408. https:\/\/doi.org\/10.1016\/S2214-109X(21)00050-4.","DOI":"10.1016\/S2214-109X(21)00050-4"},{"key":"ref_12","first-page":"573","article-title":"From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy","volume":"15","author":"Valdez","year":"2015","journal-title":"Curr. Diabetes Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1167\/iovs.11-7934","article-title":"High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes","volume":"52","author":"Trudeau","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"D\u2019Esposito, F., Cappellani, F., Visalli, F., Capobianco, M., Rapisarda, L., Avitabile, A., Cannizzaro, L., Malaguarnera, R., Gagliano, G., and Maniaci, A. (2025). Pericytes as Key Players in Retinal Diseases: A Comprehensive Narrative Review. Biology, 14.","DOI":"10.3390\/biology14070736"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-4614-3209-8_35","article-title":"Hypoxia-inducible factor (HIF)\/vascular endothelial growth factor (VEGF) signaling in the retina","volume":"801","author":"Kurihara","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2009.07.007","article-title":"Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy","volume":"148","author":"Wang","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12031-015-0621-7","article-title":"PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina","volume":"57","author":"Maugeri","year":"2015","journal-title":"J. Mol. Neurosci. MN"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2001334","DOI":"10.1002\/advs.202001334","article-title":"Human Mesenchymal Stem Cell Derived Exosomes Enhance Cell-Free Bone Regeneration by Altering Their miRNAs Profiles","volume":"7","author":"Zhai","year":"2020","journal-title":"Adv. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biomaterials.2019.01.016","article-title":"Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion","volume":"197","author":"Mathew","year":"2019","journal-title":"Biomaterials"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","year":"2015","journal-title":"Eye Vis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamaophthalmol.2023.2289","article-title":"Prevalence of diabetic retinopathy in the US in 2021","volume":"141","author":"Lundeen","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Mohammed, M.R., and Fathi, S.A. (2025). Global prevalence of diabetic retinopathy over the last decade (2015\u20132025): A scoping review. SSRN.","DOI":"10.1101\/2025.07.24.25332019"},{"key":"ref_24","first-page":"685","article-title":"Diabetes and diabetic retinopathy in Kazakhstan from 2013\u20132018","volume":"25","author":"Beisembinova","year":"2021","journal-title":"Curr. Pediatr. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"28266","DOI":"10.1038\/s41598-024-78596-9","article-title":"Prevalence of diabetic retinopathy and its associated risk factors among adults in Ethiopia: A systematic review and meta-analysis","volume":"14","author":"Wondmeneh","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zegeye, A.F., Temachu, Y.Z., and Mekonnen, C.K. (2023). Prevalence and factors associated with Diabetes retinopathy among type 2 diabetic patients at Northwest Amhara Comprehensive Specialized Hospitals, Northwest Ethiopia 2021. BMC Ophthalmol., 23.","DOI":"10.1186\/s12886-022-02746-8"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.18231\/j.ijceo.2020.082","article-title":"Prevalence of diabetic retinopathy: A tertiary care centre based study","volume":"6","author":"Mehta","year":"2020","journal-title":"Indian J. Clin. Exp. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1764","DOI":"10.1016\/S2214-109X(22)00411-9","article-title":"Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban-rural locations, and socioeconomic indices: Results from the SMART India population-based cross-sectional screening study","volume":"10","author":"Raman","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4103\/ijo.IJO_1310_21","article-title":"Prevalence of diabetic retinopahty in India: Results from the National Survey 2015-19","volume":"69","author":"Vashist","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10654-019-00560-z","article-title":"Prevalence, incidence and future projection of diabetic eye disease in Europe: A systematic review and meta-analysis","volume":"35","author":"Li","year":"2020","journal-title":"Eur. J. Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3627465","DOI":"10.1155\/2016\/3627465","article-title":"Diabetic retinopathy in Italy: Epidemiology data and telemedicine screening programs","volume":"2016","author":"Vujosevic","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e014444","DOI":"10.1136\/bmjopen-2016-014444","article-title":"Population trends in the 10-year incidence and prevalence of diabetic retinopathy in the UK: A cohort study in the Clinical Practice Research Datalink 2004\u20132014","volume":"7","author":"Mathur","year":"2017","journal-title":"BMJ Open"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1111\/aos.14927","article-title":"Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire","volume":"100","author":"Scanlon","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00125-016-4013-5","article-title":"Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: Results from the Gutenberg Health Study (GHS)","volume":"59","author":"Ponto","year":"2016","journal-title":"Diabetologia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1038\/s41467-023-39864-w","article-title":"Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China","volume":"14","author":"Hou","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wang, J., and Zhang, H. (2024). Prevalence of diabetic retinopathy and its risk factors in rural patients with type 2 diabetes referring to Beijing Huairou Hospital, China. BMC Ophthalmol., 24.","DOI":"10.1186\/s12886-024-03606-3"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41433-022-01999-3","article-title":"Diabetic retinopathy in Africa","volume":"36","author":"Bascaran","year":"2022","journal-title":"Eye"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"95881","DOI":"10.5662\/wjm.v14.i4.95881","article-title":"Diabetic retinopathy: A review on its pathophysiology and novel treatment modalities","volume":"14","author":"Morya","year":"2024","journal-title":"World J. Methodol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/ijem.ijem_480_21","article-title":"Diabetic retinopathy: An overview of treatments","volume":"26","author":"Mounirou","year":"2022","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","article-title":"Neurodegeneration in the diabetic eye: New insights and therapeutic perspectives","volume":"25","author":"Simo","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"36150","DOI":"10.1155\/2007\/36150","article-title":"A role for excitatory amino acids in diabetic eye disease","volume":"2007","author":"Pulido","year":"2007","journal-title":"Exp. Diabetes Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1167\/iovs.08-3293","article-title":"Inhibition of vitreoretinal VEGF elevation and blood\u2013retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine","volume":"51","author":"Kusari","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.1.02008","article-title":"Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF\u2013VEGF receptor 2 binding in diabetic retinopathy","volume":"37","author":"Zhang","year":"2006","journal-title":"J. Mol. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"108555","DOI":"10.1016\/j.exer.2021.108555","article-title":"Astaxanthin mediated regulation of VEGF through HIF1\u03b1 and XBP1 signaling pathway: An insight from ARPE-19 cells and streptozotocin-mediated diabetic rat model","volume":"206","author":"Janani","year":"2021","journal-title":"Exp. Eye Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"23463","DOI":"10.1074\/jbc.274.33.23463","article-title":"Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occludens-1: A potential mechanism for vascular permeability in diabetic retinopathy and tumors","volume":"274","author":"Antonetti","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Wang, W., and Lo, A.C.Y. (2018). Diabetic retinopathy: Pathophysiology and treatments. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061816"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.2174\/09298673113209990022","article-title":"Pericyte loss in diabetic retinopathy: Mechanisms and consequences","volume":"20","author":"Beltramo","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/exer.2000.0882","article-title":"Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes","volume":"71","author":"Naruse","year":"2000","journal-title":"Exp. Eye Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-1326.2007.00795.x","article-title":"Importance of pericytes and mechanisms of pericyte loss during diabetic retinopathy","volume":"10","author":"Ejaz","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra021678","article-title":"Diabetic retinopathy","volume":"350","author":"Frank","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-011-0004-8","article-title":"Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion","volume":"55","author":"Suzuki","year":"2011","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1167\/iovs.17-21973","article-title":"Assessment of neurotrophins and inflammatory mediators in vitreous of patients with diabetic retinopathy","volume":"58","author":"Boss","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10456-016-9497-6","article-title":"Bone marrow-derived cells in ocular neovascularization: Contribution and mechanisms","volume":"19","author":"Gao","year":"2016","journal-title":"Angiogenesis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101140","DOI":"10.1016\/j.disamonth.2021.101140","article-title":"Proliferative diabetic retinopathy (PDR)","volume":"67","author":"Chaudhary","year":"2021","journal-title":"Disease-a-Month"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"107307","DOI":"10.1016\/j.ejps.2025.107307","article-title":"Diabetic retinopathy in focus: Update on treatment advances, pharmaceutical approaches, and new technologies","volume":"214","author":"Ciorba","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wang, Z., Zhang, N., Lin, P., Xing, Y., and Yang, N. (2024). Recent advances in the treatment and delivery system of diabetic retinopathy. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1347864"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100262","DOI":"10.1016\/j.apjo.2025.100262","article-title":"International consensuses and guidelines on management of proliferative diabetic retinopathy (PDR) by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)","volume":"14","author":"Lam","year":"2025","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","article-title":"Long-term outcomes of ranibizumab therapy for diabetic macular edema: The 36-month results from two phase III trials: RISE and RIDE","volume":"120","author":"Brown","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): Two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ophtha.2024.05.025","article-title":"Efficacy of Faricimab versus Aflibercept in Diabetic Macular Edema in the 20\/50 or Worse Vision Subgroup in Phase III YOSEMITE and RHINE Trials","volume":"131","author":"Zarbin","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Gao, M., Liu, C., Zeng, Y., Wu, X., and Duan, J. (2025). Progress in the treatment of diabetic macular edema with faricimab: A review. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1682311"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e002234","DOI":"10.1136\/bmjophth-2025-002234","article-title":"Impact of anti-VEGF treatment for diabetic macular oedema on progression to proliferative diabetic retinopathy: Data-driven insights from a multicentre study","volume":"10","author":"Lilaonitkul","year":"2025","journal-title":"BMJ Open Ophthalmol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","article-title":"Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials","volume":"131","author":"Wong","year":"2024","journal-title":"Ophthalmology"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Esteban-Flor\u00eda, O., Mateo, J., Lara, J., Bartolom\u00e9, I., Herrero, I., P\u00e9rez, M.A., Cabello, C., Honrubia, A., Pinilla, I., and Ascaso, J. (2025). Efficacy and safety of faricimab in diabetic macular edema: Real-world outcomes in treatment-na\u00efve and previously treated eyes. J. Clin. Med., 14.","DOI":"10.3390\/jcm14176173"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaophthalmol.2025.0001","article-title":"Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial","volume":"143","author":"Pieramici","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40123-023-00843-5","article-title":"Clinical Trials and Future Outlooks of the Port Delivery System with Ranibizumab: A Narrative Review","volume":"13","author":"Lowater","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"K\u0105pa, M., Koryciarz, I., Kustosik, N., Jurowski, P., and Pniakowska, Z. (2025). Future Directions in Diabetic Retinopathy Treatment: Stem Cell Therapy, Nanotechnology, and PPAR\u03b1 Modulation. J. Clin. Med., 14.","DOI":"10.3390\/jcm14030683"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wang, S., Hua, R., Zhao, Y., and Liu, L. (2024). Laser Treatment for Diabetic Retinopathy: History, Mechanism, and Novel Technologies. J. Clin. Med., 13.","DOI":"10.3390\/jcm13185439"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s00417-023-06134-w","article-title":"Refining vitrectomy for proliferative diabetic retinopathy","volume":"261","author":"Chen","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.4103\/IJO.IJO_30_24","article-title":"Vitrectomy for cases of diabetic retinopathy","volume":"72","author":"Shaikh","year":"2024","journal-title":"Indian J. Ophthalmol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcyt.2024.02.020","article-title":"Clinical-grade human embryonic stem cell-derived mesenchymal stromal cells ameliorate diabetic retinopathy in db\/db mice","volume":"26","author":"Rong","year":"2024","journal-title":"Cytotherapy"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Sun, F., Sun, Y., Wu, F., Xu, W., and Qian, H. (2022). Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapy for Diabetes Mellitus and Diabetic Complications. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102208"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4103\/NRR.NRR-D-24-01619","article-title":"Effects and mechanisms of adipose tissue-derived extracellular vesicles in vascular inflammation and dysfunction","volume":"21","author":"Lintsen","year":"2026","journal-title":"Neural Regen. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"110046","DOI":"10.1016\/j.exer.2024.110046","article-title":"Research on the role of exosomes secreted by immortalized adipose-derived mesenchymal stem cells differentiated into pericytes in the repair of high glucose-induced retinal vascular endothelial cell damage","volume":"247","author":"Wu","year":"2024","journal-title":"Exp. Eye Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Sharma, K., Zhang, Y., Paudel, K.R., Kachelmeier, A., Hansbro, P.M., and Shi, X. (2022). The emerging role of pericyte-derived extracellular vesicles in vascular and neurological health. Cells, 11.","DOI":"10.3390\/cells11193108"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Aheget, H., Mazini, L., Martin, F., Belqat, B., Marchal, J.A., and Benabdellah, K. (2020). Exosomes: Their role in pathogenesis, diagnosis and treatment of diseases. Cancers, 13.","DOI":"10.3390\/cancers13010084"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s12951-025-03589-3","article-title":"Recent advances in engineered exosome-based therapies for ocular vascular disease","volume":"23","author":"Guan","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12967-022-03493-6","article-title":"Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases","volume":"20","author":"Fan","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/011574888X393159250704132425","article-title":"Mesenchymal stem cell-derived exosomes in the treatment of skin and subcutaneous tissue diseases: A review","volume":"1","author":"Dairov","year":"2026","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-024-06659-w","article-title":"Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications","volume":"15","author":"Jiao","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e43989","DOI":"10.1097\/MD.0000000000043989","article-title":"Exosomes derived from mesenchymal stem cells mediate miR-218 and inhibit proliferation, migration, and oxidative stress in retinal vascular endothelial cells via the EGFR\/Akt\/mTOR signaling pathway","volume":"104","author":"Zhang","year":"2025","journal-title":"Medicine"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.18240\/ijo.2021.11.06","article-title":"Protective effect of human umbilical cord mesenchymal stem cell-derived exosomes on rat retinal neurons in hyperglycemia through the brain-derived neurotrophic factor\/TrkB pathway","volume":"14","author":"Gao","year":"2021","journal-title":"Int. J. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"119232","DOI":"10.1016\/j.lfs.2021.119232","article-title":"MSC-derived exosomal lncRNA SNHG7 suppresses endothelial-mesenchymal transition and tube formation in diabetic retinopathy via miR-34a-5p\/XBP1 axis","volume":"272","author":"Cao","year":"2021","journal-title":"Life Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"110768","DOI":"10.1016\/j.exer.2025.110768","article-title":"Small extracellular vesicles derived from human retinal pericytes under high glucose and hypoxia conditions promote endothelial cell dysfunction in vitro","volume":"263","author":"Nandeesh","year":"2025","journal-title":"Exp. Eye Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Lupo, G., Agafonova, A., Cosentino, A., Giurdanella, G., Mannino, G., Lo Furno, D., Romano, I.R., Giuffrida, R., D\u2019Angeli, F., and Anfuso, C.D. (2023). Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24020913"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Rajashekhar, G., Ramadan, A., Abburi, C., Callaghan, B., O Traktuev, D., Evans-Molina, C., Maturi, R., Harris, A., Kern, T.S., and March, K.L. (2014). Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084671"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mendel, T.A., Clabough, E.B.D., Kao, D.S., Demidova-Rice, T.N., Durham, J.T., Zotter, B.C., A Seaman, S., Cronk, S.M., Rakoczy, E.P., and Katz, A.J. (2013). Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS ONE, 8, Erratum in PLoS ONE\u00a02013, 8. https:\/\/doi.org\/10.1371\/annotation\/679017bf-abd5-44ce-9e20-5e7af1cd3468.","DOI":"10.1371\/annotation\/679017bf-abd5-44ce-9e20-5e7af1cd3468"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/stem.2726","article-title":"The pericytic phenotype of adipose tissue-derived stromal cells is promoted by NOTCH2","volume":"36","author":"Terlizzi","year":"2018","journal-title":"Stem Cells"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"107865","DOI":"10.1016\/j.exer.2019.107865","article-title":"Effects of intravitreal injection of human CD34+ bone marrow stem cells in a murine model of diabetic retinopathy","volume":"190","author":"Yazdanyar","year":"2020","journal-title":"Exp. Eye Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13287-022-02983-0","article-title":"Mesenchymal stem cells-derived small extracellular vesicles alleviate diabetic retinopathy by delivering NEDD4","volume":"13","author":"Sun","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1002\/jcp.30213","article-title":"Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1","volume":"236","author":"Gu","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","article-title":"Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication","volume":"21","author":"Mathieu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","article-title":"Exosomes","volume":"88","author":"Pegtel","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Witwer","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Coco-Martin, R.M., Pastor-Idoate, S., and Pastor, J.C. (2021). Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges. Pharmaceutics, 13.","DOI":"10.20944\/preprints202105.0217.v1"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Salvetat, M.L., Pellegrini, F., Spadea, L., Salati, C., and Zeppieri, M. (2023). Non-Arteritic Anterior Ischemic Optic Neuropathy (NA-AION): A Comprehensive Overview. Vision, 7.","DOI":"10.3390\/vision7040072"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Bianco, L., Arrigo, A., Aragona, E., Antropoli, A., Berni, A., Saladino, A., Parodi, M.B., and Bandello, F. (2022). Neuroinflammation and neurodegeneration in diabetic retinopathy. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.937999"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Hang, A., Feldman, S., Amin, A.P., Ochoa, J.A.R., and Park, S.S. (2023). Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders. Pharmaceuticals, 16.","DOI":"10.3390\/ph16081140"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.survophthal.2025.08.002","article-title":"Laser-induced histopathological changes to the retina: A review","volume":"71","author":"Gowda","year":"2026","journal-title":"Surv. Ophthalmol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/0301-4738.178146","article-title":"Does tight control of systemic factors help in the management of diabetic retinopathy?","volume":"64","author":"Rajalakshmi","year":"2016","journal-title":"Indian J. Ophthalmol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","article-title":"Stem cell-based therapy for human diseases","volume":"7","author":"Hoang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000492838","article-title":"Efficacy and Safety of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with Diabetic Retinopathy","volume":"49","author":"Gu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_108","unstructured":"(2026, July 03). A Pilot Clinical Trial of the Feasibility and Safety of Intravitreal Autologous Adult Bone Marrow Stem Cells in Treating Eyes with Vision Loss From Retinopathy, Available online: https:\/\/clinicaltrials.gov\/study\/NCT01736059."},{"key":"ref_109","unstructured":"(2026, July 03). Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy, Available online: https:\/\/clinicaltrials.gov\/study\/NCT03403699."},{"key":"ref_110","unstructured":"(2026, July 03). A Comparison of Islet Cell Transplantation with Medical Therapy on the Risk of Progression of Diabetic Retinopathy and Diabetic Macular Edema, Available online: https:\/\/clinicaltrials.gov\/study\/NCT00853424."},{"key":"ref_111","unstructured":"(2026, July 03). Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Non-Arteritic Ischemic Optic Neuropathy, Available online: https:\/\/clinicaltrials.gov\/study\/NCT05147701."},{"key":"ref_112","unstructured":"(2026, July 03). Proteomic Study of Plasma Exosomes in Patients with Diabetic Retinopathy, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06188013."},{"key":"ref_113","unstructured":"(2026, July 03). Study on Exosome Changes in Patients with Proliferative Diabetic Retinopathy, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06198543."},{"key":"ref_114","unstructured":"(2026, July 03). Prognostic Role of Serum Exosomal miRNA and Its Function in Pathogenesis of Diabetic Retinopathy (DR), Available online: https:\/\/clinicaltrials.gov\/study\/NCT03264976."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00125-014-3197-9","article-title":"miR-195 regulates SIRT1-mediated changes in diabetic retinopathy","volume":"57","author":"Mortuza","year":"2014","journal-title":"Diabetologia"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"26909","DOI":"10.1038\/srep26909","article-title":"MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6354\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:06:47Z","timestamp":1784279207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/14\/6354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":117,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27146354"],"URL":"https:\/\/doi.org\/10.3390\/ijms27146354","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}